Normalizing data in the Adverse Event Reporting System (AERS), an FDA database, would improve the mining capacity of AERS for drug safety signal detection. In this study, we aim to normalize AERS and build a publicly available normalized Adverse drug events (ADE) data source. The drug ...
As of October 5, 2006, the FDA's Adverse Event Reporting System has received 8 cases of HSTCL in young patients using infliximab, a tumor necrosis ... A Corken,Mackey,Lanh,... - 《Journal of Pediatric Gastroenterology & Nutrition》 被引量: 994发表: 2007年 Transfusion-related acute lung ...
19. FDA, FDA Adverse Event Reporting System (FAERS). Database. (2015) Available at: http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm. (Accessed: 10th June 2015). 20. Okon, E., Engell, C., van Manen, R. & Brown, J. Tigecycline...
[1]Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System.DOI:10.3389/fphar.2022.1063625 [2]Signal of Miscarriage with Aripiprazole: A Disproportionalit...
Objective: Signal detection by analyzing adverse event spontaneous report databases is used to monitor drug safety. One of the major spontaneous report databases is the FDA Adverse Event Reporting System (FAERS). Recently, the Japanese Adverse Drug Event Report database (JADER) was released. To com...
Operation ID: DrugAdverseEvent The openFDA drug adverse event API returns data that has been collected from the FDA Adverse Event Reporting System (FAERS), a database that contains information on adverse event and medication error reports submitted to FDA. Parameters 展開資料表 NameKeyRequiredType...
Adverse Event Reporting System (FAERS). Chi-squared test was conducted to discover which treatment regimens or drugs had sex differences in adverse events. Moreover, reporting odds ratio (ROR) andPvalue were calculated to quantify the signals of sex differences for specific drug-event combinations....
BackgroundThe Adverse Event Reporting System is the primary surveillance database used by the Food and Drug Administration for identifying postmarketing
To assess completeness of reports in the Saudi Adverse Event Reporting System (SAERS), which is a part of the Saudi Food and Drug Authority pharmacovigilance system for monitoring the safety of medications. A cross-sectional study was conducted in Riyadh, Saudi Arabia using the reports that were...
BACKGROUND: To examine how closely reporting rates in the FDA Adverse Event Reporting System (FAERS) reflect expected rates of known adverse drug events (ADEs). METHODS: We selected three groups of drugs to reflect hypothesized variation in sensitivity to reporting, including statins, biologics, and...